Systolic Blood Pressure Reduction with Tirzepatide across SURPASS Program: A Mediation Analysis Using Weight Loss as a Factor

被引:1
|
作者
Lingvay, Ildiko
Mosenzon, Ofri
Brown, Katelyn
Cui, Xuewei
Lando, Laura Fernandez
Patel, Hiren
机构
关键词
D O I
10.2337/db22-716-P
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
716-P
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Systolic blood pressure reduction with tirzepatide across SURPASS programme: a mediation analysis using weight loss as a factor
    Mosenzon, O.
    Lingvay, I.
    Brown, K.
    Cui, X.
    Lando, L. Fernandez
    Patel, H.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S284 - S285
  • [2] Systolic blood pressure reduction with tirzepatide in patients with type 2 diabetes: insights from SURPASS clinical program
    Lingvay, Ildiko
    Mosenzon, Ofri
    Brown, Katelyn
    Cui, Xuewei
    O'Neill, Ciara
    Lando, Laura Fernandez
    Patel, Hiren
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [3] Systolic blood pressure reduction with tirzepatide in patients with type 2 diabetes: insights from SURPASS clinical program
    Ildiko Lingvay
    Ofri Mosenzon
    Katelyn Brown
    Xuewei Cui
    Ciara O’Neill
    Laura Fernández Landó
    Hiren Patel
    Cardiovascular Diabetology, 22
  • [4] HbA1c reduction with tirzepatide in people with type 2 diabetes: a mediation analysis using body weight loss as a factor
    Vilsboll, T.
    Nicolay, C.
    Malecki, M.
    Thieu, V. Thuyanh
    Chivukula, K.
    Kiljanski, J.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S324 - S325
  • [5] Weight Loss and Reduction of Blood Pressure and Hypertension
    Kuller, Lewis H.
    HYPERTENSION, 2009, 54 (04) : 700 - 701
  • [6] WEIGHT-LOSS AND REDUCTION IN BLOOD-PRESSURE
    YOUNG, JB
    LANDSBERG, L
    NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (18): : 1033 - 1033
  • [7] Total cholesterol, arterial stiffness, and systolic blood pressure: a mediation analysis
    Haojia Chen
    Youren Chen
    Weiqiang Wu
    Zefeng Cai
    Zhichao Chen
    Xiuzhu Yan
    Shouling Wu
    Scientific Reports, 11
  • [8] Total cholesterol, arterial stiffness, and systolic blood pressure: a mediation analysis
    Chen, Haojia
    Chen, Youren
    Wu, Weiqiang
    Cai, Zefeng
    Chen, Zhichao
    Yan, Xiuzhu
    Wu, Shouling
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [9] Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program
    Nicholls, Stephen J.
    Tofe, Santiago
    le Roux, Carel W.
    D'Alessio, David A.
    Wiese, Russell J.
    Pavo, Imre
    Brown, Katelyn
    Weerakkody, Govinda J.
    Zeytinoglu, Meltem
    Romera, Irene C.
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [10] Time spent in glycaemic control with sustained body weight reduction with tirzepatide: A post hoc analysis of the SURPASS clinical trial programme
    Bergman, Brandon K.
    Rosenstock, Julio
    Garvey, W. Timothy
    Batterham, Rachel L.
    Chen, Yanyun
    Liu, Minzhi
    Sharma, Palash
    Karanikas, Chrisanthi A.
    Thieu, Vivian T.
    DIABETES OBESITY & METABOLISM, 2025,